Proxalutamide

  • CAT Number: I008887
  • CAS Number: 1398046-21-3
  • Molecular Formula: C24H19F4N5O2S
  • Molecular Weight: 517.503
  • Purity: ≥95%
Inquiry Now

Proxalutamide (CAT: I008887) is a novel androgen receptor antagonist that exhibits anti-androgenic effects. It selectively binds to androgen receptors, inhibiting the binding of endogenous androgens and the activation of androgen receptor signaling. Proxalutamide has shown promise in the treatment of prostate cancer by suppressing tumor growth and inhibiting androgen receptor-mediated signaling pathways. Additionally, it has potential applications in the management of androgen-dependent conditions, such as androgenic alopecia and hirsutism. Clinical trials are underway to evaluate the efficacy, safety, and optimal dosage of proxalutamide in various androgen-related disorders, providing a potential therapeutic option for patients in need.


Catalog Number I008887
CAS Number 1398046-21-3
Synonyms

Proxalutamide; GT-0918; GT 0918; GT0918;4-(4,4-dimethyl-3-(6-(3-(oxazol-2-yl)propyl)pyridin-3-yl)-5-oxo-2-thioxoimidazolidin-1-yl)-3-fluoro-2-(trifluoromethyl)benzonitrile

Molecular Formula C24H19F4N5O2S
Purity ≥95%
Target Androgen Receptor Antagonist
Solubility Soluble in DMSO
Storage 0 - 4 °C for short term, or -20 °C for long term
IUPAC Name 4-[4,4-dimethyl-3-[6-[3-(1,3-oxazol-2-yl)propyl]pyridin-3-yl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-3-fluoro-2-(trifluoromethyl)benzonitrile
InChI InChI=1S/C24H19F4N5O2S/c1-23(2)21(34)32(17-9-6-14(12-29)19(20(17)25)24(26,27)28)22(36)33(23)16-8-7-15(31-13-16)4-3-5-18-30-10-11-35-18/h6-11,13H,3-5H2,1-2H3
InChIKey KCBJGVDOSBKVKP-UHFFFAOYSA-N
SMILES CC1(C(=O)N(C(=S)N1C2=CN=C(C=C2)CCCC3=NC=CO3)C4=C(C(=C(C=C4)C#N)C(F)(F)F)F)C
Reference

</br>1: Yang M, He S, Fan Y, Wang Y, Ge Z, Shan L, Gong W, Huang X, Tong Y, Gao C. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo. Int J Pharm. 2014 Nov 20;475(1-2):97-109. doi: 10.1016/j.ijpharm.2014.08.047. PubMed PMID: 25171976.</br>2: Peng Y, Wu H, Zhang X, Zhang F, Qi H, Zhong Y, Wang Y, Sang H, Wang G, Sun J. A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug-drug interaction evaluation. Xenobiotica. 2015;45(11):961-77. doi: 10.3109/00498254.2015.1036954. PubMed PMID: 26007223.

Request a Quote